HPV Vaccination during the COVID-19 Pandemic in Italy: Opportunity Loss or Incremental Cost
Objectives: Italy was the first European country to introduce universal vaccination of adolescents, for both males and females, against Human Papilloma Virus (HPV) starting in 2017 with the NIP 2017–2019′s release. However, vaccine coverage rates (VCRs) among adolescents have shown a precarious take...
Main Authors: | Francesco Saverio Mennini, Andrea Silenzi, Andrea Marcellusi, Michele Conversano, Andrea Siddu, Giovanni Rezza |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-07-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/10/7/1133 |
Similar Items
-
Role of RWD / RWE in health technology assessment
by: V. G. Borovskaya, et al.
Published: (2023-03-01) -
HPV infection and breast cancer risk: insights from a nationwide population study in Taiwan
by: Chuck Lin, et al.
Published: (2023-07-01) -
The Right Choice for Production Patterns to Minimize Cost of Incremental
by: Erick Wijaya, et al.
Published: (2011-05-01) -
What is needed to successfully implement the EU HTA Regulation enabling broad patient access in Europe
by: Oriol Solà-Morales, et al.
Published: (2025-01-01) -
Criteria adopted in different models of public healthcare systems for the evaluation of reimbursement recommendations of orphan drugs: a scoping review.
by: Arturo Felippini, et al.
Published: (2023-11-01)